Free Trial

William Blair Issues Negative Forecast for InnovAge Earnings

InnovAge logo with Medical background

InnovAge Holding Corp. (NASDAQ:INNV - Free Report) - Research analysts at William Blair decreased their Q3 2025 EPS estimates for shares of InnovAge in a research note issued on Tuesday, November 5th. William Blair analyst J. Haase now expects that the company will post earnings per share of ($0.02) for the quarter, down from their previous forecast of ($0.01). The consensus estimate for InnovAge's current full-year earnings is ($0.02) per share. William Blair also issued estimates for InnovAge's FY2025 earnings at ($0.06) EPS.

InnovAge (NASDAQ:INNV - Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The company reported ($0.04) EPS for the quarter, hitting analysts' consensus estimates of ($0.04). InnovAge had a negative net margin of 2.79% and a negative return on equity of 7.43%. The business had revenue of $205.14 million during the quarter, compared to analysts' expectations of $203.35 million. During the same period last year, the company posted ($0.08) earnings per share.

Separately, KeyCorp assumed coverage on InnovAge in a report on Friday, October 11th. They set a "sector weight" rating for the company.

Get Our Latest Stock Analysis on INNV

InnovAge Stock Down 1.0 %

Shares of INNV traded down $0.06 during trading hours on Friday, hitting $6.00. The stock had a trading volume of 46,031 shares, compared to its average volume of 37,225. The firm has a 50 day simple moving average of $5.91 and a 200-day simple moving average of $5.39. InnovAge has a 1-year low of $3.52 and a 1-year high of $6.69. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.25 and a quick ratio of 1.25. The firm has a market capitalization of $813 million, a P/E ratio of -37.50 and a beta of 0.39.

Insider Buying and Selling

In other news, insider Nicole Damato sold 4,372 shares of the stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $5.95, for a total value of $26,013.40. Following the completion of the sale, the insider now directly owns 240,795 shares of the company's stock, valued at $1,432,730.25. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.40% of the stock is currently owned by company insiders.

Institutional Trading of InnovAge

Institutional investors have recently made changes to their positions in the company. Renaissance Technologies LLC lifted its position in shares of InnovAge by 3.1% during the second quarter. Renaissance Technologies LLC now owns 136,400 shares of the company's stock valued at $677,000 after purchasing an additional 4,100 shares in the last quarter. Rhumbline Advisers lifted its position in shares of InnovAge by 7.0% during the 2nd quarter. Rhumbline Advisers now owns 27,503 shares of the company's stock worth $136,000 after buying an additional 1,793 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of InnovAge by 27.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 58,322 shares of the company's stock worth $289,000 after buying an additional 12,448 shares during the last quarter. Accordant Advisory Group Inc bought a new position in shares of InnovAge in the second quarter valued at approximately $496,000. Finally, Kent Lake Capital LLC grew its holdings in shares of InnovAge by 3.7% in the first quarter. Kent Lake Capital LLC now owns 1,750,000 shares of the company's stock valued at $7,770,000 after acquiring an additional 62,141 shares in the last quarter. Institutional investors own 12.26% of the company's stock.

InnovAge Company Profile

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Featured Stories

Earnings History and Estimates for InnovAge (NASDAQ:INNV)

Should you invest $1,000 in InnovAge right now?

Before you consider InnovAge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.

While InnovAge currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines